Stock PERRIGO COMPANY
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Perrigo Company Nasdaq

Equities

US7142901039

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Perrigo Company
06-13 Piper Sandler Adjusts Price Target on Perrigo to $36 From $39, Maintains Overweight Rating MT
06-11 Transcript : Perrigo Company plc Presents at Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference, Jun-11-2024 01:30 PM

Chart calendar Perrigo Company

6d8788d.Zn2e4BB9tAS8H96LZloYSRKPyYhQQwqNHuwvMUqF8qw.PBDwqWIT2FXMT-i_BQxtGEbCg_hiM13EJ41oCAC1xptUKs3NUhnEfoVdjw~60da167f102a1e1194227c37ec24f829

Upcoming events on Perrigo Company

2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-02 Q4 2024 Earnings Release (Projected)
2025-05-12 Q1 2025 Earnings Release (Projected)

Past events on Perrigo Company

2024-06-11 13:30 Oppenheimer Consumer Growth and E Commerce Virtual Conference
2024-05-30 Détachement de
2024-05-07 08:30 Q1 2024 Earnings Call
2024-05-07 06:30 Q1 2024 Earnings Release
2024-05-02 05:00 Annual General Meeting
2024-03-13 16:00 UBS Global Consumer and Retail Conference
2024-03-06 Détachement de
2024-02-27 08:30 Q4 2023 Earnings Call
2024-02-27 06:30 Q4 2023 Earnings Release
2023-12-06 13:30 Morgan Stanley Global Consumer & Retail Conference
2023-11-29 Détachement de
2023-11-14 Jefferies Miami Consumer Conference
2023-11-07 08:30 Q3 2023 Earnings Call
2023-11-07 06:30 Q3 2023 Earnings Release
2023-09-12 11:00 Piper Sandler Growth Frontiers Conference
2023-09-06 Barclays Global Consumer Staples Conference
2023-08-30 Détachement de
2023-08-09 10:30 Canaccord Genuity Growth Conference
2023-08-08 08:30 Q2 2023 Earnings Call
2023-08-08 06:30 Q2 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		4 837
4 814
0.48%		5 063
5 107
-0.86%		4 139
4 126
0.3%		4 452
4 520
-1.52%		4 656
4 667
-0.25%
4 620

EBITDA
Million USD		Released
Forecast
Spread 		894
910
-1.76%		886
907
-2.35%		578
553
4.55%		577
580
-0.59%		664
789
-15.84%
716

EBIT
Million USD		Released
Forecast
Spread 		809
815
-0.7%		796
809
-1.65%		479
475
0.74%		492
496
-0.81%		574
582
-1.35%
611

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		171
449
-61.92%		0,00
0,00
- 		0,00
0,00
- 		-139
-177
21.19%		-8,30
76,3
-110.88%
-138

Net income
Million USD		Released
Forecast
Spread 		146
272
-46.2%		-163
89,2
-282.39%		-68,9
-94,0
26.7%		-141
0,00
- 		-12,7
40,9
-131.03%
-73,7

EPS
USD		Released
Forecast
Spread 		1,07
2,04
-47.42%		-1,19
0,68
-275%		-0,52
-0,99
47.47%		-1,04
0,00
- 		-0,09
0,22
-140.91%
-1,45

Announcement Date27/02/2001/03/2101/03/2227/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		1 075
1 057
1.65%		1 122
1 065
5.35%		1 100
1 142
-3.66%		1 155
1 200
-3.75%		1 182
1 172
0.84%		1 193
1 181
1.03%		1 124
1 200
-6.38%		1 157
1 169
-0.99%		1 082
1 111
-2.59%
1 158


1 162


1 218


1 137


1 188

EBITDA
Million USD		Released
Forecast
Spread 		107
131
-18.23%		137
140
-2.18%		153
163
-5.95%		179
181
-1.27%		143
174
-17.85%		162
151
7.1%		173
167
3.9%		187
200
-6.61%		116
111
4.27%
164


203


224


190


207

EBIT
Million USD		Released
Forecast
Spread 		86,8
104
-16.77%		116
112
4.12%		133
156
-14.87%		156
160
-2.44%		120
118
1.7%		137
133
3.19%		150
150
0.4%		167
175
-4.5%		93,0
91,2
1.97%
138


179


202


168


178

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread





-3,50
-37,2
90.59%		-14,3
-18,0
20.56%		4,30








-54,4
30,3
-279.83%		-98,6
-62,6
-57.51%
-43,8


-6,95


11,2


49,0


59,0

Net income
Million USD		Released
Forecast
Spread





-49,4
-28,6
-72.73%		-23,7
-13,9
-70.5%


8,40
-54,2
115.5%


-32,3
20,0
-261.77%		2,00
-52,0
103.85%
-32,0


-4,70


-38,9


36,8


44,8

EPS
USD		Released
Forecast
Spread





-0,37
-0,21
-76.19%		-0,17


-0,02
0,10
-120%		0,06
-0,40
115%


-0,24
0,03
-900%

















Announcement Date11/05/2209/08/2208/11/2227/02/2309/05/2308/08/2307/11/2327/02/2407/05/24-----

Upcoming sector events for Perrigo Company

2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 06:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 DR. REDDY'S LABORATORIES LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Perrigo Company

Today HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-06-21 11:28 DEVA HOLDING: Q1 2024 Earnings Release
2024-06-13 17:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
2024-06-11 01:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
2024-06-07 06:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
2024-06-07 05:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
2024-05-30 08:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 FDC LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. PRGO Stock
  4. Stock
  5. Calendar Perrigo Company